A Phase 1 Clinical Trial to Investigate Pharmacokinetics and Drug Interaction of Crestor and Glucodown OR SR in Healthy Volunteers

Inclusion Criteria: * 20\~50 yrs old, healthy Korean Subjects * Body weight \<ideal body weight±20% * No congenital, chronic disease, No current disease * Subjects who are diagnosed to include by medical doctor from laboratory and ECG result. * Subjects who agree to keep contraceptive methods during the clinical trial. Exclusion Criteria: * Subjects who are allergic to investigational drug. * Subjects who have a medical history which can affect the clinical trial. * Hypertension(Systolic BP ≥ 150mmHG or Diastolic BP ≥ 100mmHg), Hypotension(Systolic BP ≤ 100mmHg or Diastolic BP ≤ 65mmHg) * Subjects who have taken other medicine in recent 2\~4 weeks. * Subjects who have a risk of hypoglycemia and imbalance in taking a diet.